BioSenic S.A. (EBR:BIOS)
Belgium · Delayed Price · Currency is EUR 0.0022
0.00 (0.00%)
Apr 30, 2026, 5:35 PM CET
BioSenic Market Cap
BioSenic has a market cap or net worth of €1.44 million as of May 1, 2026. Its market cap has increased by 46.67% in one year.
Market Cap
1.44M
Enterprise Value
24.46M
Revenue
-2.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since October 26, 2022, BioSenic's market cap has decreased from 7.09M to 1.44M, a decrease of -79.75%. That is a compound annual growth rate of -36.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 1.44M | -4.35% |
| Dec 31, 2025 | 1.50M | -20.08% |
| Dec 31, 2024 | 1.88M | -81.19% |
| Dec 29, 2023 | 9.99M | 233.11% |
| Dec 30, 2022 | 3.00M | -57.74% |
| Oct 26, 2022 | 7.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 43.06B |
| argenx SE | 41.39B |
| Financière de Tubize | 8.71B |
| Onward Medical | 184.25M |
| Hyloris Pharmaceuticals | 149.52M |
| European Medical Solutions | 21.16M |
| Celyad Oncology | 14.23M |
| Oxurion NV | 337.03K |